Government-Protected ‘Monopolies’ Drive Drug Prices Higher, Study Says
Researchers at Harvard University examined thousands of studies to determine why drug prices have climbed and what might be done about it.
The independent source for health policy research, polling, and news.
841 - 860 of 1,578 Results
Researchers at Harvard University examined thousands of studies to determine why drug prices have climbed and what might be done about it.
A year after settling billing disputes with 2,022 hospitals for 68 cents on the dollar, the government has revealed who got paid and how much.
A conversation with author David Barton Smith examines how civil rights activists working at the Social Security Administration and the Public Health Service in the 1960s used the new Medicare law to end racial discrimination at hospitals.
Medicare will withhold an estimated $528 million in 2017 from more than 2,500 hospitals that have too many patients returning within 30 days.
Of the 102 hospitals that received a five-star rating, few are among the elite generally praised for great care.
Concerns raised as health insurers automatically move members of their marketplace or individual plans who are eligible for Medicare.
The U.S. Preventive Services Task Force concluded that insufficient evidence exists regarding the benefits and harms of visual skin cancer exams.
The government will soon give hospitals one to five stars to sum up their quality. Some safety hospitals and teaching hospitals won’t fare as well as other facilities.
The incidence of opioid use disorder is growing rapidly within the Medicare population.
Federal spending has soared for drugs that are handmade in local pharmacies, and federal investigators are raising concerns about fraud or overbilling.
Researchers found that nearly 15 percent of seniors filled prescriptions for an opioid painkiller after leaving the hospital and of those, 42.5 percent had the order refilled later.
A Kaiser Family Foundation analysis sheds new light on a widely-held belief about the costs of end-of-life care.
Advocates for a single payer health care system say it would be more efficient, but other analysts predict that such an unprecedented change could be extremely disruptive to a key part of the nation’s economy.
The president made the proposal as part of a comprehensive look at the Affordable Care Act’s legacy in an article under his byline in the Journal of the American Medical Association.
The decision runs counter to a Senate committee that voted to strip the $52 million appropriation for the State Health Insurance Assistance Program, which helps beneficiaries understand their Medicare coverage and helps them with billing issues.
A new health benefit available to millions of Californians encourages people to discuss end-of-life care options with their doctors.
A Health Affairs study determines that Part D spending went down slightly on prescription drugs for which medical marijuana is viewed as a possible alternative.
A study in Health Affairs finds Medicare Part D beneficiaries were charged copays averaging 10.5 times more for Crestor and Nexium than generic drugs would have cost them.
The changes announced Tuesday seek to eliminate the backlog by 2021.
The U.S Preventive Services Task Force recently expanded the list of approved colorectal cancer screening tests. Here’s a primer on these various tests and how they might be covered now and in the future by health insurance.
© 2026 KFF